We Help Companies Find New Sales Opportunities
British Biotech is forming an alliance with MerLion Pharmaceuticals of Singapore to develop anti-bacterial treatments from natural products.
British Biotech is to merge with RiboTargets, creating a combined biotechnology group with a market value of £52m.
British Biotech is seeking acquisitions and research collaborations in Europe and North America in order to expand its portfolio of drugs.
British Biotech is forming an alliance with Serono of Switzerland to develop new treatments for inflammatory diseases.
British Biotech is planning to focus on the development of antibiotics, in order to reinvent itself following the disappointing results from its marimastat cancer drug.